Distinct pathways for tumor necrosis factor alpha and ceramides in human cytomegalovirus infection

Journal of Virology

Volumn 72, Issue 3, 1998, Pages 2316-2322

  Allan Yorke, Justine ^a   Record, Michel ^a   De Préval, Claude ^a   Davrinche, Christian ^a   Davignon, Jean Luc ^a,b  

^a INSERM   (France)

^b CHU PURPAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CERAMIDE; SPHINGOMYELIN PHOSPHODIESTERASE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ASTROCYTOMA CELL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; VIRUS INHIBITION; VIRUS REPLICATION;

EID: 0031911649     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.3.2316-2322.1998     Document Type: Article

References (50)

1. Bligh, E. G., and W. J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37:911-918.
2. Boucher, L.-M., K. Wiegmann, A. Fütterer, K. Pfeffer, T. Machleidt, S. Schütze, T. W. Mak, and M. Krönke. 1995. CD28 signals through acidic sphingomyelinase. J. Exp. Med. 181:2059-2068.
3. Bresnahan, W. A., I. Boldogh, E. Aubrey Thomson, and T. Albrecht. 1996. Human cytomegalovirus inhibits cellular DNA synthesis and arrests productively infected cells in late G1. Virology 224:150-160.
4. Britt, W. J., and C. A. Alford. 1996. Cytomegalovirus, p. 2493-2523. In B. N. Fields (ed.), Virology, 3rd ed. Lippincott-Raven Publishers, Philadelphia, Pa.
5. Brockhaus, M., H.-J. Schoenfeld, E.-J. Schlaeger, W. Hunziker, W. Lesslauer, and H. Loetscher. 1990. Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc. Natl. Acad. Sci. USA 87:3127-3131.
6. Coroneos, E., Y. Wang, J. R. Panuska, D. J. Templeton, and M. Kester. 1996. Sphingolipid metabolites differentially regulate extracellular signal-regulated kinase and stress-activated protein kinase cascades. Biochem. J. 316:13-17.
7. + T-cell clones specifically activated by IE1 peptides in vitro. J. Virol. 70:2162-2169.
8. 1/S transition. J. Virol. 71:1629-1634.
9. Futerman, A. H., B. Stieger, A. L. Hubbard, and R. E. Pagano. 1990. Sphingomyelin synthesis in rat liver occurs predominantly at the cis and medial cisternae of the Golgi apparatus. J. Biol. Chem. 265:8650-8657.
10. Hauser, J. M. L., B. M. Buehrer, and R. M. Bell. 1994. Role of ceramide in mitogenesis induced by exogenous sphingoid bases. J. Biol. Chem. 269:6803-6809.
11. Jarvis, W. D., R. N. Kolesnick, F. A. Fornari, R. S. Traylor, D. A. Gewirtz, and S. Grant 1994. Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway. Proc. Natl. Acad. Sci. USA 91:73-77.
12. Jault, F. M., J.-M. Jault, F. Ruchti, E. A. Fortunate, C. Clark, J. Corbeil, D. D. Richman, and D. H. Spector. 1995. Cytomegalovirus infection induces high levels of cyclins, phosphorylated Rb and p53, leading to cell cycle arrest. J. Virol. 69:6697-6704.
13. Jayadev, S., B. Liu, A. E. Bielawska, J. Y. Lee, F. Nazaire, M. Y. Pushkareva, L. M. Obeid, and Y. A. Hannun. 1995. Role for ceramide in cell cycle arrest. J. Biol. Chem. 270:2047-2052.
14. Ji, L., G. Zhang, S. Uematsu, Y. Akahori, and Y. Hirabayashi. 1995. Induction of apoptotic DNA fragmentation and cell death by natural ceramide. FEBS Lett. 358:211-214.
15. Karupiah, G., Q.-W. Xie, R. M. Buller, C. Nathan, C. Duarte, and J. D. MacMicking. 1993. Inhibition of viral replication by interferon-γ-induced nitric oxide synthase. Science 261:1445-1448.
16. Kim, M.-Y., C. Linardic, L. Obeid, and Y. Hannun. 1991. Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor-α and γ-interferon. J. Biol. Chem. 266:484-489.
17. Lin, Z.-G., H. Hsu, D. V. Goeddel, and M. Karin. 1996. Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death. Cell 87:565-576.
18. 1 to S. J. Virol. 70:8850-8857.
19. Mathias, S., K. A. Dressler, and R. N. Kolesnick. 1991. Characterization of a ceramide-activated protein kinase: stimulation by tumor necrosis factor α. Proc. Natl. Acad. Sci. USA 88:10009-10013.
20. Mestan, J., W. Digel, S. Mittnacht, H. Hillen, D. Blohm, A. Möller, H. Jacobsen, and H. Kirchner. 1986. Antiviral effects of recombinant tumour necrosis factor in vitro. Nature 323:816-819.
21. Natoli, G., A. Costanzo, A. Ianni, D. J. Templeton, J. R. Woodget, C. Balsano, and M. Levrero. 1996. Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway. Science 275:200-203.
22. Nelson, J. A., C. Reynolds-Kohler, M. B. A. Oldstone, and C. A. Wiley. 1988. HIV and HCMV coinfect brain cells in patients with AIDS. Virology 165: 286-290.
23. Obeid, L. M., C. M. Linardic, L. A. Karolak, and Y. Hannun. 1993. Programmed cell death induced by ceramide. Science 259:1769-1771.
24. Olivera, A., N. E. Buckley, and S. Spiegel. 1992. Sphingomyelinase and cell-permeable ceramide analogs stimulate cellular proliferation in quiescent Swiss 3T3 fibroblasts. J. Biol. Chem. 267:26121-26127.
25. Pavic, I., B. Polic, I. Crnkovic, P. Lucin, S. Jonjic, and U. H. Koszninowski. 1993. Participation of endogenous tumor necrosis factor α in host resistance to cytomegalovirus infection. J. Gen. Virol. 74:2215-2223.
26. Paya, C. V., R. M. Ten, C. Bessia, J. Alcami, R. T. Hay, and J. L. Virelizier. 1992. NF-κB-dependent induction of the NF-κB p50 subunit gene promoter underlies self-perpetuation of human immunodeficiency virus transcription in monocytic cells. Proc. Natl. Acad. Sci. USA 89:7826-7830.
27. Poli, G., A. Kinter, J. S. Justement, J. H. Kehrl, P. Bressler, S. Stanley, and A. S. Fauci. 1990. Tumor necrosis factor a functions in an autocrine manner in the induction of human immunodeficiency virus expression. Proc. Natl. Acad. Sci. USA 87:782-785.
28. Preiss, J., C. R. Loomis, W. R. Bishop, R. Stein, J. E. Niedel, and R. M. Bell. 1986. Quantative measurement of sn-1,2-diacylglycerols present in platelets, hepatocytes, and ras- and sis-transformed normal rat kidney cells. J. Biol. Chem. 261:8597-8600.
29. Pusztai, L., C. E. Lewis, and J. O'D. McGee. 1993. Growth arrest of the breast cancer cell line, T47D, by TNFα: cell cycle specificity and signal transduction. Br. J. Cancer 67:290-296.
30. Raines, M. A., R. N. Kolesnick, and D. W. Golde. 1993. Spingomyelinase and ceramide activate mitogen-activated protein kinase in myeloid HL-60 cells. J. Biol. Chem. 268:14572-14575.
31. Rivas, C. I., D. W. Golde, J. C. Vera, and R. N. Kolesnick. 1994. Involvement of the sphingomyelin pathway in autocrine tumor necrosis factor signaling for human immunodeficiency virus production in chronically infected HL-60 cells. Blood 83:2191-2197.
32. Robinson, M. J., and M. H. Cobb. 1997. Mitogen-activated protein kinase pathways. Curr. Opin. Cell Biol. 9:180-186.
33. Rosenwald, A. G., and R. E. Pagano. 1993. Inhibition of glycoprotein traffic through the secretory pathway by ceramide. J. Biol. Chem. 268:4577-4579.
34. Schütze, S., K. Potthoff, T. Machleidt, D. Berkovic, K. Wiegmann, and M. Krönke. 1992. TNF activates NF-κB by phosphatidylcholine-specific phospholipase C-induced "acidic" sphingomyelin breakdown. Cell 71:765-776.
35. Slowik, M. R., L. G. Deluca, W. Min, and J. S. Pober. 1996. Ceramide is not a signal for tumor necrosis factor-induced gene expression but does cause programmed cell death in human vascular endothelial cells. Circ. Res. 79: 736-747.
36. Sluss, H. K., T. Barrett, B. Dérijard, and R. J. Davis. 1994. Signal transduction by tumor necrosis factor mediated by JNK protein kinases. Mol. Cell. Biol. 14:8376-8384.
37. St. Jeor, S. C., T. B. Albrecht, F. D. Funk, and F. Rapp. 1974. Stimulation of cellular DNA synthesis by human cytomegalovirus. J. Virol. 13:353-362.
38. Tartaglia, L. A., M. Rothe, Y. F. Hu, and D. V. Goeddel. 1993. Tumor necrosis factor's cytotoxic activity is signaled by the p55 receptor. Cell 73: 213-216.
39. Tartaglia, L. A., T. M. Ayres, G. H. W. Wong, and D. V. Goeddel. 1993. A novel domain within the 55 kd TNF receptor signals cell death. Cell 74:845-853.
40. Vassalli, P. 1992. The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10:411-452.
41. Venable, M. E., J. Y. Lee, M. J. Smyth, A. Bielawska, and L. M. Obeid. 1995. Role of ceramide in cellular senescence. J. Biol. Chem. 270:30701-30708.
42. Vindelov, L. L., and I. J. Christensen. 1990. A review of techniques and results obtained in one laboratory by an integrated system of methods designed for routine clinical flow cytometric analysis. Cytometry 11:753-770.
43. Wentworth, B. B., and L. French. 1970. Plaque assay of cytomegalovirus strains of human origin. Proc. Soc. Exp. Biol. Med. 135:253-258.
44. Westwick, J. K., A. E. Bielawska, G. Dbaibo, Y. A. Hannun, and D. A. Brenner. 1995. Ceramide activates the stress-activated protein kinases. J. Biol. Chem. 270:22689-22692.
45. Wiegmann, K., S. Schütze, E. Kampen, A. Himmler, T. Machleidt, and M. Krönke. 1992. Human 55-kDa receptor for tumor necrosis factor coupled to signal transduction cascades. J. Biol. Chem. 267:17997-18001.
46. Wiegmann, K., S. Schütze, T. Machleidt, D. Witte, and M. Krönke. 1994. Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell 78:1005-1015.
47. Wong, G. H., and D. V. Goeddel. 1986. Tumour necrosis factors α and β inhibit virus replication and synergize with interferons. Nature 323:819-822.
48. Wong, G. H. W., L. A. Tartaglia, M. S. Lee, and D. V. Goeddel. 1992. Antiviral activity of tumor necrosis factor is signaled through the 55-kDa type I TNF receptor. J. Immunol. 149:3350-3353.
49. Wong, G. H. W., J. Krowka, D. P. Stites, and D. V. Goeddel. 1988. In vitro anti-human immunodeficiency virus activities of tumor necrosis factor-α and interferon-γ. J. Immunol. 140:120-124.
50. Zhang, P., B. Lia, G. M. Jenkins, Y. Hannun, and L. M. Obeid. 1997. Expression of neutral sphingomyelinase identifies a distinct pool of sphingomyelin involved in apoptosis. J. Biol. Chem. 272:9609-9612.